Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
about
An event-related FMRI study of phonological verbal working memory in schizophreniaAntipsychotic drug treatment for elderly people with late-onset schizophreniaRisperidone versus typical antipsychotic medication for schizophreniaNicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.The cytokine model of schizophrenia: emerging therapeutic strategiesNeuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidolNovel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.[Treatment of cognitive deficits in schizophrenia. Part 2: Pharmacological strategies].Improving outcome in schizophrenia: the case for early interventionA comparative review of new antipsychotics.Cognitive deficits and cognitive training in schizophrenic patients: a review.Fortnightly review. Treatment of schizophrenia.Switching antipsychotic therapies.Measuring neuropsychological change in schizophrenia with novel antipsychotic medicationsTreating cognitive dysfunction in patients with schizophreniaEffect of second-generation antipsychotics on cognition: current issues and future challenges.Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophreniaPatient compliance with drug therapy in schizophrenia. Economic and clinical issues.Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.Treatment-refractory schizophrenia.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophreniaEfficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical studyInvestigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences.Conceptualization of the liability for schizophrenia: clinical implications.Schizophrenia: family studies and treatment of spectrum disordersImproved antisaccade performance with risperidone in schizophreniaCognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders.Cognition, schizophrenia, and the atypical antipsychotic drugsPharmacogenetic studies of response to risperidone and other newer atypical antipsychotics.Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations.The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.Risperidone and ritanserin but not haloperidol block effect of dizocilpine on the active allothetic place avoidance taskSymptom domains of schizophrenia: the role of atypical antipsychotic agents.The relationship between patient satisfaction and treatment outcomes in schizophrenia.The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes.Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.
P2860
Q21136187-08EEDD90-9CB9-4CF6-8883-96DA49D864B6Q24203649-3FC2F1A9-E382-4307-BA36-5B59C4BE897DQ24248755-949784AF-F1D0-4FC1-84D4-D1A2CDD4A730Q24532028-986CDC50-EFA9-402B-B886-C68EA26EC300Q26865996-B0A0A2DD-28E0-432E-ACA4-D24CE420FCB3Q28362116-ED72CC10-E5D5-4256-9CDF-B8BA4F78CE81Q30501297-4EAC2118-1F05-4B3E-A988-7A47C6D7D392Q33223628-9B563BBA-71C2-436A-946F-463B54D95580Q33535963-980B1808-C021-45C8-8335-03A2676980E1Q33585800-B48773F2-C897-44EE-9B5F-305995162614Q33606079-22C97058-6D63-4F11-ABEA-B45DB299AF2CQ33729924-AD3D8C25-F269-4ADA-99C0-16C2FEA88FCBQ33751787-5BD5D1C9-F210-4A9A-9627-F9F78390FF48Q33838916-DEA5BE87-1026-4A02-8A1B-35167FF69226Q33877837-F65C90EC-7C3B-4F33-9ED5-CA49696F49C4Q33877844-E6619F9C-5FA2-4E40-AD88-9734C4EAAC4EQ33888153-4EB159BF-6557-47AA-AFC2-386683FEC72BQ33976994-E3F5E625-662E-4BE1-B871-831775D140D0Q34078005-6F8245E0-24B8-43CF-897B-5B048CDDC33BQ34338202-3D04A499-C595-4DDA-BAF4-B3A667DB7C7AQ34370955-7FD99274-8D15-4BC9-963E-B02AD5C6E120Q34640811-183D7435-640A-40B2-AF4E-7F1D1B1C088DQ34642323-A5911C08-96AB-45B9-B27F-0A003BE82F5CQ34665354-2B6EA375-37F3-4062-9C87-6D3CF37A1494Q34703195-F4A08E56-F865-4DA9-9297-9929E405AC69Q35073807-862BED84-3DEF-42F5-B166-66DBBB51E24AQ35236187-6300EA18-1D79-4BB8-A25B-9A5BA333B9BAQ35236290-0DCDEF1F-3DA8-444C-9EA7-803AF48782C8Q35466566-27AE03E5-ED12-48F7-BD02-A4E5BB1649F8Q35618437-B92A4222-EC62-4B85-B6D4-38BCE064C69EQ36086075-5C04587F-040A-47A6-862D-3910F73BD102Q36120821-FC16C337-041A-473E-8620-F0DD6038F94BQ36401912-C4318125-915C-4D29-A373-8554C33A1047Q36414518-6463AC4A-C7EC-4162-9227-54A4F5B74232Q36442322-3DFFA457-629D-4E7B-B6C3-BAA1A7B9FEFFQ36458968-E9935C3A-3B0B-43E5-8A85-525097B858A6Q36626242-D47528F8-F8AC-40E0-8FA7-DEFD3011D1BDQ36626251-94C75952-8A18-4378-B8B0-26F835BED322Q36652587-1095AE64-B8D6-47B5-9EB0-8ADD1C701931Q36676697-ED3A2933-E000-4F4E-9337-9BF799B6AD75
P2860
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
@en
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
@nl
type
label
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
@en
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
@nl
prefLabel
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
@en
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
@nl
P2093
P356
P1476
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
@en
P2093
Marshall BD Jr
Wirshing WC
P304
P356
10.1176/AJP.154.6.799
P407
P577
1997-06-01T00:00:00Z